Sign up
Login
Friday 17th November 2017
13:20 Welcome and introduction (D. Betticher, Fribourg)
Open questions in lymphoma and CLL (A. Moccia)
13:30 The new WHO classification: what changes for the clinician? (S. Dirnhofer, Basel)
14:10 Has PET replaced all other imaging in lymphoma? (L. Ceriani, Bellinzona)
14:50 Does radiotherapy still have a role in lymphoma treatment? (T. Illidge, Manchester)
15:30 Coffee Break
16:00 Should all treatments of Hodgkin lymphoma be (PET-)response-adapted? (A. Moccia, Bellinzona)
16:40 Is genetics-based treatment of DLBCL ready to be applied to patients? (U. Novak, Bern)
17:20 Burkitt and lymphoblastic lymphoma: which regimens should we use? (F. Stenner, Basel)
18:00 Adjourn
Saturday 18th November 2017
Open questions in lymphoma and CLL (M. Ghielmini)
08:00 T-cell lymphomas: any progress in the last 20 years? (F. Hitz, St. Gallen)
08:40 Is there a standard treatment for Mantle Cell lymphoma? (U. Mey, Chur)
09:20 CNS lymphoma and CNS prophylaxis: is high-dose chemo the solution? (A. Ferreri, Milano)
10:00 Coffee Break
10:30 Follicular lymphoma: the end of chemotherapy? (M. Ghielmini, Bellinzona)
11:10 Should Marginal Zone lymphomas be treated as follicular lymphomas? (M. Raderer, Vienna)
11:50 CLL: have new drugs made allogeneic transplantation obsolete? (D. Rossi, Bellinzona)
12:30 Wrap up and closure
This Website uses Cookies. If you continue to use the website, you accept the use of Cookies. You will find more information in our notes on data protection. Accept